Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies
Mimmi L. E. Lundahl, Silvia Fogli, Paula E. Colavita, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 4, pp. 1004-1020
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Exploring the next generation of antibody–drug conjugates
Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 203-223
Open Access | Times Cited: 184
Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy
Jonas Kaltbeitzel, Peter Wich
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 44
Open Access | Times Cited: 50
Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems
Miusi Shi, Kevin J. McHugh
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114904-114904
Open Access | Times Cited: 50
Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies
Chantal T. Harris, Sivan Cohen
BioDrugs (2024) Vol. 38, Iss. 2, pp. 205-226
Open Access | Times Cited: 24
US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives
Shawn Shouye Wang, Yifei Yan, K. Lee Ho
Antibody Therapeutics (2021) Vol. 4, Iss. 4, pp. 262-272
Open Access | Times Cited: 81
Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins
Mohsen Akbarian, Shu‐Hui Chen
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2533-2533
Open Access | Times Cited: 61
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry
Mahdie Rahban, Faizan Ahmad, Mieczyslaw A. Piatyszek, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35947-35963
Open Access | Times Cited: 33
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
Frances Rocamora, Angelo G. Peralta, Seunghyeon Shin, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108206-108206
Open Access | Times Cited: 23
A Review of Recent Developments in Biopolymer Nano-Based Drug Delivery Systems with Antioxidative Properties: Insights into the Last Five Years
Magdalena Stevanović, Nenad Filipović
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 670-670
Open Access | Times Cited: 11
Enhanced and Prolonged Immunogenicity in Mice of Thermally Stabilized Fatty Acid-Conjugated Vaccine Antigen
Bo Mi Kim, Yeonho Kim, Hai V. Ngo, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 168-168
Open Access | Times Cited: 1
Unraveling the Effects of Filtration, Process Interruptions, and Post-Process Agitation on Protein Aggregation
Christina Winter, Anthony Springer, Jean-Gérard Descamps, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access | Times Cited: 1
Automated optimisation of solubility and conformational stability of antibodies and proteins
Angelo Rosace, Anja Bennett, Marc Oeller, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity
Michael U. Martin, Juergen Frevert, Clifton Ming Tay
Toxins (2024) Vol. 16, Iss. 2, pp. 101-101
Open Access | Times Cited: 6
Unraveling the Microscopic Mechanism of Molecular Ion Interaction with Monoclonal Antibodies: Impact on Protein Aggregation
Suman Saurabh, Qinkun Zhang, John M. Seddon, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1285-1299
Open Access | Times Cited: 6
Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics
Kuin Tian Pang, Yuansheng Yang, Wei Zhang, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108192-108192
Open Access | Times Cited: 14
Design Principles for Immunomodulatory Biomaterials
Samuel Abidemi Oluwole, Welday Desta Weldu, Keerthana Jayaraman, et al.
ACS Applied Bio Materials (2024)
Closed Access | Times Cited: 5
In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody
Kaewta Rattanapisit, Christine Joy I. Bulaon, Richard Strasser, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer’s disease
Tobias Gustavsson, Nicole G. Metzendorf, Elin Wik, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems
Mir Salar Kazemi, Alireza Shoari, Neda Salehibakhsh, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124258-124258
Closed Access | Times Cited: 4
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 4
Strategy to mitigate aggregation during Protein A chromatography and low pH virus inactivation for a nivolumab biosimilar candidate
Elizabeth Pargas-Ferrer, Sum Lai Lozada Chang, Katia García, et al.
Journal of Chromatography A (2025) Vol. 1743, pp. 465698-465698
Closed Access
AggNet: Advancing protein aggregation analysis through deep learning and protein language model
Wenjia He, Xiaopeng Xu, Haoyang Li, et al.
Protein Science (2025) Vol. 34, Iss. 2
Closed Access
Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies
Erin L. Howard, Melanie M. Goens, Leonardo Susta, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 299-299
Open Access
Advances in nanobody multimerization and multispecificity: from in vivo assembly to in vitro production
Mohammed Al‐Seragi, Yilun Chen, Franck Duong
Biochemical Society Transactions (2025) Vol. 53, Iss. 01
Open Access
Pre-Concentration Freezing Alters the Composition of Mesenchymal Stem/Stromal Cell-Conditioned Medium
Francesca Cadelano, Chiara Giannasi, Alice Gualerzi, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 181-181
Open Access
Page 1 - Next Page

Scroll to top